SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Sabra Health Care REIT, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$19.08−0.26 (-1.34%)
Close on Oct 19, 2026
- Market cap
- $4.81B
- P/E (TTM)
- 73.4
- Dividend yield
- 6.29%
Sabra Health Care REIT statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Real Estate Investment Trusts companies for comparison
Valuation
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Market Cap | $4.87B | $302.70M |
| Enterprise Value | $4.64B | $294.25M |
| PE Ratio | 73.38 | 23.24 |
| PS Ratio | 5.67 | 4.20 |
| PB Ratio | 1.77 | 1.69 |
| P/TBV Ratio | 1.83 | 1.81 |
| P/OCF Ratio | 13.12 | 12.25 |
Enterprise value
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| EV / Sales | 5.40 | 4.06 |
| EV / EBITDA | 12.04 | 9.41 |
Income (trailing twelve months)
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Revenue | $859.56M | $462.89M |
| Pretax Income | $60.35M | $15.47M |
| Net Income | $65.44M | $5.29M |
| EBITDA | $385.80M | $7.15M |
| EPS (Diluted) | $0.26 | $0.51 |
Margins
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Pretax Margin | 7.02% | 13.2% |
| Profit Margin | 7.61% | 10.6% |
| EBITDA Margin | 44.9% | 46.5% |
Returns
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Return on Equity (ROE) | 2.40% | 4.88% |
| Return on Assets (ROA) | 1.21% | 1.89% |
Growth
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 17.3% | 4.40% |
| Net Income Growth (YoY) | -64.1% | 12.0% |
| EPS Growth (YoY) | -65.8% | 9.29% |
| Revenue Growth (3Y CAGR) | 7.43% | 4.15% |
| Revenue Growth (5Y CAGR) | 5.29% | 7.74% |
| EPS Growth (5Y CAGR) | -0.91% | 6.21% |
Balance sheet
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $231.58M | $1.13M |
| Net Cash (Debt) | $231.58M | $863.61K |
| Net Cash Per Share | $0.91 | $0.04 |
| Equity (Book Value) | $2.75B | -$35.82K |
| Book Value Per Share | $10.77 | -$0.00 |
| Tangible Book Value | $2.67B | -$75.49K |
Cash flow (trailing twelve months)
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Operating Cash Flow | $371.57M | $15.25M |
Efficiency
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Asset Turnover | 0.16 | 0.13 |
| Revenue Per Employee | $14.82M | $2.35M |
| Profits Per Employee | $1.13M | $123.21K |
| Employee Count | 58 | 64 |
Dividends and yields
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Earnings Yield | 1.34% | 2.12% |
| Dividend Yield | 6.29% | 5.74% |
| Shareholder Yield | 6.29% | 5.07% |
| Dividend Per Share | $1.20 | $1.34 |
| Dividend Growth (YoY) | 0.00% | 1.18% |
| Years of Dividend Growth | 0 | 1 |
| Payout Ratio | 455.5% | 120.7% |
Shares
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Shares Outstanding | 255,463,000 | 30,666,700 |
| Shares Change (YoY) | 4.89% | 0.70% |
| Shares Change (QoQ) | 1.30% | 0.01% |
| Float | 250,629,000 | 24,140,050 |
| Shares Held by Insiders | 1.89% | 17.4% |
| Shares Held by Institutions | 102.1% | 68.6% |
Taxes
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Income Tax | $2.13M | $279.50K |
| Effective Tax Rate | 3.53% | 2.25% |
Scores
| Measure | Sabra Health Care REIT | Industry median |
|---|---|---|
| Graham Number | $7.94 | $20.29 |
| Graham Upside | -58.4% | -29.1% |
| Altman Z-Score | 1.22 | 6.12 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Sabra Health Care REIT's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.